Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
1.220
+0.040 (3.39%)
Sep 8, 2025, 1:37 PM EDT
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of $3.04 million as of September 8, 2025. Its market cap has decreased by -65.52% in one year.
Market Cap
3.04M
Enterprise Value
13.71M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.22
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 34.16M to 3.04M, a decrease of -91.09%. That is a compound annual growth rate of -7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 3.04M | -77.60% |
| Dec 31, 2024 | 13.59M | -32.53% |
| Dec 29, 2023 | 20.15M | -62.12% |
| Dec 30, 2022 | 53.19M | -56.27% |
| Dec 31, 2021 | 121.64M | -68.80% |
| Dec 31, 2020 | 389.84M | -9.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |